The effects of glucagon‐like peptide (GLP)‐1 receptor agonists on weight and glycaemic control in Prader–Willi syndrome: A systematic review-Reference-Cited by-同舟云学术

The effects of glucagon‐like peptide (GLP)‐1 receptor agonists on weight and glycaemic control in Prader–Willi syndrome: A systematic review

Author:

Ng Nicholas Beng Hui¹^ORCID,Low Yue Wey²,Rajgor Dimple Dayaram¹³,Low Jia Ming⁴,Lim Yvonne Yijuan¹,Loke Kah Yin¹³,Lee Yung Seng¹³^ORCID

Affiliation:

1. Department of Paediatrics, Khoo Teck Puat–National University Children's Medical Institute National University Hospital Singapore Singapore

2. Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

3. Department of Paediatrics, Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

4. Department of Neonatology, Khoo Teck Puat–National University Children's Medical Institute National University Hospital Singapore Singapore

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

Reference46 articles.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献